Navigation Links
Cytopia Announces Novel Anti-Cancer Drug Development Collaboration
Date:5/9/2008

cancer drugs from Australia's research base. It will undertake responsibility for the further development of Cytopia's early compounds towards a preclinical candidate compound which is capable of further development into and through clinical trials.

"We are delighted to be embarking on a collaboration of this type with a leading Australian drug development company such as Cytopia," said Tony Evans, CEO of Cancer Therapeutics. "Our company was founded with the vision to aid in the further development of Australian biotechnology industry by applying drug discovery and development capabilities to early research findings and take on projects that are in the high risk category from commercial organizations or academic institutions to unlock their commercial potential."

Cytopia's advanced anti-cancer drug is being tested in four clinical programs covering oral and IV doses in Phase I and Phase II level studies. Trials are advanced for both oral and injectable vascular disrupting agents (VDAs), multiple myeloma and an aggressive brain tumor glioblastoma multiforme (GBM).

About Cytopia

Cytopia Ltd is an Australian biotechnology company focused on the discovery and development of new drugs to treat cancer and other diseases. Cytopia conducts its research and development via subsidiaries based in Melbourne, Australia and New York and specializes in discovering new molecules with an improved therapeutic profile for the treatment of cancer. Cytopia's lead compound, CYT997, is currently in Phase II clinical trials.

Website: http://www.cytopia.com.au

About Cancer Therapeutics

Cancer Therapeutics CRC Pty Ltd has been formed through a collaboration between a number of Australia's leading research institutions and commercial organizations for the purposes of cancer drug discovery and development. It is funded under the Australian Government's CRC scheme. The objective of the Compa
'/>"/>

SOURCE Cytopia Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Cytopia Nominates JAK2 Clinical Candidate for Myeloproliferative Disorders
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Dec. 15 Reportlinker.com announces ... is available in its catalogue: ,, ... Industry in the U.S. and its ... ,, http://www.reportlinker.com/p0167745/Surgical-and-Medical-Instrument-Manufacturing-Industry-in-the-US-and-its-International-Trade-[Q4-2009-Edition].html ,, The ... and Medical Instrument Manufacturing Industry report ...
(Date:12/15/2009)... YORK, Dec. 15 Reportlinker.com ... report is available in its catalogue: ... strategic assessment of the competitive environment ... priority management responsibilities, the task crucial ... Timely and factual competitive intelligence is ...
(Date:12/15/2009)... At today,s regular meeting of the board of directors ... the board declared a regular quarterly dividend of 31 ... of record at the close of business on February ... ,, The Lubrizol Corporation (NYSE: LZ ) ... supplies technologies that improve the quality and performance of ...
Breaking Medicine Technology:Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 2Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 3Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 4Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 5Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 6Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 7Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 8Reportlinker Adds Top Ten World's Leading Orthopedics Companies 2Reportlinker Adds Top Ten World's Leading Orthopedics Companies 3Lubrizol Declares Dividend 2Sogo Photographs for a Cause Founder Wins Place in International Exhibition 59029 1Sogo Photographs for a Cause Founder Wins Place in International Exhibition 59029 2The 24th Annual Great Sports Legends Dinner Raises More Than 246 3 Million for the Buoniconti Fund to Cure Paralysis 59026 1The 24th Annual Great Sports Legends Dinner Raises More Than 246 3 Million for the Buoniconti Fund to Cure Paralysis 59026 2The 24th Annual Great Sports Legends Dinner Raises More Than 246 3 Million for the Buoniconti Fund to Cure Paralysis 59026 3The California Center for Cardiothoracic Surgery 28heart411 com 29 Surgeons are Leaders in Lung Cancer Surgery 59022 1The California Center for Cardiothoracic Surgery 28heart411 com 29 Surgeons are Leaders in Lung Cancer Surgery 59022 2
(Date:12/15/2009)... to be leaders in the fight against malaria ... experts in online learning, the Masie Center and ... -- ONE and Malaria No More ... first-ever "Malaria Griots" program, a dynamic education course ... leaders in the fight against malaria. ,, ...
(Date:12/15/2009)... Dec. 15 The following are the ... for the criminal division, at the Medicare Fraud ... Sebelius. And thank you for the enormous effort ... initiative. ,, Together, our Departments have and ... ,, We,ve made tremendous progress in fighting Medicare ...
(Date:12/15/2009)... A new study links chronic obstructive pulmonary disease, ... as sentinels to activate the body,s immune system. ... adds to growing awareness of the immune system,s role ... more than 12 million Americans with wheezing, shortness of ... is key if doctors are to find better ways ...
(Date:12/15/2009)... still too early to say that phthalates ... Dec. 15 (HealthDay News) -- Common chemicals found ... the abnormal growth of breasts in boys, preliminary ... a prominent medical journal for pediatricians, adds fuel ... whose safety has been questioned by some scientists. ...
(Date:12/15/2009)... It,s nearly as accurate a surgical method, with fewer ... -- When it comes to diagnosing breast cancer, women ... suggests that the less invasive "core needle biopsy" procedure ... an open surgical procedure is, with fewer complications than ... published in the Jan. 5 issue of Annals ...
Breaking Medicine News(10 mins):Health News:ONE and Malaria No More Launch 'Malaria Griots' 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 4Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 2Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 3Health News:Immune cell activity linked to worsening COPD 2Health News:Immune cell activity linked to worsening COPD 3Health News:Breast Growth in Boys Might Be Linked to Plastics Chemical 2Health News:Breast Growth in Boys Might Be Linked to Plastics Chemical 3Health News:Needle Biopsy Works Well in Diagnosing Breast Cancer 2
... inflammatory disorders like rheumatoid arthritis may be reduced ... oranges, carrots and sweetcorn. //, ,Vitamin C ... found in brightly-coloured fruit and veg, may act ... oxidative damage and inflammation. ,The levels of ...
... the disease tuberculosis has been identified which, is held to ... known to be involved in a number of other diseases ... the gene are held to control the speed at which ... speed at which people develop tuberculosis. HIV and tuberculosis are ...
... Researchers from University of Michigan had identified a protein ... sensori-neural hearing loss or AISNHL.//, ,In the August ... Neck Surgery, researchers reports results from a study of ... Pennsylvania and Indiana, and 20 people with normal hearing. ...
... ultrasound to be used in the outpatient department in ... //,Focused ultrasound is a welcome advance in treating this ... women over age 40, because it is the first ... tumors. Women leave the doctor’s office the same day, ...
... in UK shops were contaminated with Super bugs. The study ... indiscriminate use of antibiotics in animals and to // protect ... ,Super bugs are multiple drug resistant bacteria. British ... resistant E.coli which is immune to the effects of three ...
... were produced from Human embryonic stem cells by Researchers from ... used to produce the required cell type. The nerve stem ... system. // The new nerve stem cells can be ... ,The university's Dr Steven Pollard said: "This is incredibly ...
Other Medicine News:Health News:Outpatient Treatment Possible For Patients with Uterine Fibroid Tumors 2Health News:Super Bugs Contaminate UK Chickens 2
Indications For Usage: ,Adult (recommended tidal volume >150ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to ...
Indications For Usage: ,Pediatric (recommended tidal volume 70-250ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intend...
... Thermovent® T helps provide protection to the exposed ... and extremely lightweight making it ideal for active ... high rate of heat and moisture recovery, it ... ,All HMEs and filters have ISO standard tapered ...
... Since 1991 Intersurgical ... breathing filters, heat and ... oxygen therapy products, hand-held ... range of accessories and ...
Medicine Products: